AI Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

AI Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Aviwell Secures €11M Series A Funding Led by Blue Revolution Fund
Series A

Aviwell Secures €11M Series A Funding Led by Blue Revolution Fund

•January 27, 2026
•Jan 27, 2026
0

Participants

Aviwell

Aviwell

company

MFS Investment Management

MFS Investment Management

investor

Blue Revolution Fund

Blue Revolution Fund

investor

Blast.Club

Blast.Club

investor

SWEN CAPITAL PARTNERS

SWEN CAPITAL PARTNERS

investor

Elaia

Elaia

investor

Why It Matters

The investment accelerates a technology that can meet rising global protein demand while delivering antibiotic‑free, environmentally‑friendly animal feed, reshaping the agri‑food value chain.

Key Takeaways

  • •Series A raised €11 million led by Blue Revolution Fund
  • •Aneto AI platform designs native bacterial ecologies for livestock
  • •Focus on poultry and aquaculture to replace antibiotics
  • •Funding accelerates scale‑up, validation, and commercial partnerships
  • •Investors see sustainability and performance gains as market drivers

Pulse Analysis

The animal‑protein market is confronting two converging pressures: soaring demand and tightening regulations on antibiotic use. AI‑enabled microbiome engineering offers a promising route to reconcile productivity with sustainability, and Aviwell’s Aneto platform sits at the forefront of this shift. By decoding complex bacterial interactions and linking them to specific performance traits, the technology can generate targeted probiotic consortia that improve feed conversion ratios and bolster immune resilience without chemical additives.

Aviwell’s approach differentiates itself through a deep‑tech stack that merges high‑throughput microbiota sequencing, machine‑learning models, and mechanistic biology. This integration shortens discovery timelines from years to months and cuts development costs, delivering a competitive edge in a market where speed to market is critical. Early trials in poultry and aquaculture have demonstrated measurable gains in growth rates and disease resistance, positioning Aneto as a scalable alternative to traditional feed additives and aligning with consumer preferences for natural, antibiotic‑free products.

The €11 million Series A, backed by sustainability‑focused investors such as Blue Revolution Fund, Blast.Club, and SWEN Capital Partners, validates the commercial potential of AI‑driven microbiome solutions. The capital infusion will expand Aneto’s service portfolio, accelerate scale‑up of microbial ecologies, and deepen strategic partnerships across the agri‑food ecosystem. As investors increasingly allocate capital toward climate‑positive agri‑tech, Aviwell is poised to capture a growing share of the protein supply chain, driving both economic returns and measurable environmental impact.

Deal Summary

French deep‑tech animal nutrition startup Aviwell announced the close of an €11 million Series A round, led by Blue Revolution Fund with participation from Blast.Club, SWEN Capital Partners, Elaia and MFS Investment Management. The funding will be used to scale its AI‑driven microbiome platform, Aneto, and expand sustainable nutrition solutions for poultry and aquaculture.

0

Comments

Want to join the conversation?

Loading comments...